礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LLY 礼来

休市中 12-05 16:00:00 EST

1,010.31

-4.18

-0.41%

盘后1,014.40

+4.09+0.40%

19:59 EST

最高1,027.39	最低1,004.00	成交量250.20万
今开1,023.84	昨收1,014.49	日振幅2.31%
总市值9,551亿	流通市值9,547亿	总股本9.45亿
成交额25.32亿	换手率0.26%	流通股本9.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":1010.31,"timestamp":1764968400000,"preClose":1014.49,"halted":0,"volume":2501986,"hourTrading":{"tag":"盘后","latestPrice":1014.4,"preClose":1010.31,"latestTime":"19:59 EST","volume":129260,"amount":130610252.570401,"timestamp":1764982758602},"delay":0,"floatShares":944999999,"shares":945383757,"eps":20.442104,"marketStatus":"休市中","change":-4.18,"latestTime":"12-05 16:00:00 EST","open":1023.84,"high":1027.3899,"low":1004,"amount":2531539959.0292,"amplitude":0.023056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":20.442104,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":102488400000,"exchange":"NYSE","adjPreClose":1014.49,"dividendRate":0.005741,"preHourTrading":{"tag":"盘前","latestPrice":1019.8,"preClose":1014.49,"latestTime":"09:29 EST","volume":5676,"amount":5775464.74824,"timestamp":1764944997600},"postHourTrading":{"tag":"盘后","latestPrice":1014.4,"preClose":1010.31,"latestTime":"19:59 EST","volume":129260,"amount":130610252.570401,"timestamp":1764982758602},"volumeRatio":0.7635614688470416,"impliedVol":0.3234,"impliedVolPercentile":0.156},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2589600168","title":"BMO Capital上调礼来目标价至1200美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589600168","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589600168?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:57","pubTimestamp":1764925022,"startTime":"0","endTime":"0","summary":"BMO Capital将礼来的目标价从1100美元上调至1200美元，维持“跑赢大盘”评级。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251205/31847267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LLY","BMO"],"gpt_icon":0},{"id":"1150556774","title":"美FDA批准礼来Jaypirca（Pirtobrutinib）扩大适应症，成为首个也是唯一一个针对已接受共价Btk抑制剂治疗的复发或难治性CLL/SLL成年患者的非共价（可逆）Btk抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1150556774","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150556774?lang=zh_cn&edition=full","pubTime":"2025-12-04 02:01","pubTimestamp":1764784875,"startTime":"0","endTime":"0","summary":"美FDA批准礼来Jaypirca（Pirtobrutinib）扩大适应症，成为首个也是唯一一个针对已接受共价Btk抑制剂治疗的复发或难治性CLL/SLL成年患者的非共价（可逆）Btk抑制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","LU1127390331.HKD","LU2461242641.AUD","LU2456880835.USD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU2750360641.GBP","LU2237443895.HKD","SGXZ81514606.USD","BK4007","BK4585","LU2746668974.SGD","LU1323610961.USD","BK4599","IE00B2B36J28.USD","LU2063271972.USD","LU2023250504.SGD","LU2491049909.HKD","IE0004445239.USD","IE00BK4W5M84.HKD","LU0079474960.USD","IE00BJJMRZ35.SGD","BK4516","BK4534","LU1917777945.USD","LU2471134952.CNY","LU1064131342.USD","LU1983299246.USD","LU1720051017.SGD","LU2237443465.HKD","LU1267930730.SGD","LU2462157665.USD","LU1804176565.USD","LU0672654240.SGD","LU0354030438.USD","LU1868836914.USD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0471298694.HKD","LU0266013472.USD","LU1868836591.USD","LU2237443549.SGD","LU2087625088.SGD","LU0320765992.SGD","LU0109394709.USD","LU1061106388.HKD","LU0256863902.USD","GB00BDT5M118.USD","SGXZ99366536.SGD","SG9999018865.SGD","LU0353189680.USD","LU2211815571.USD","LU0820561818.USD","SG9999001176.USD","LU0385154629.USD","LU0466842654.USD","LU1720051108.HKD","LU0786609619.USD","LU0238689110.USD","LU2264538146.SGD","LU2471134879.HKD","LU2168564149.EUR","LU2468319806.SGD","LU2471134796.USD","SG9999015978.USD","LU0943347566.SGD","LU2108987350.USD","SG9999013999.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU0109391861.USD","IE00BKDWB100.SGD","LU0289739699.SGD","LU0640476718.USD","LU0889565916.HKD","LU0353189763.USD","SGXZ51526630.SGD","LU2237443622.USD","LU2089984988.USD","BK4588","LU0058720904.USD","LU0198837287.USD","LU0234572021.USD","LU2168564065.EUR","LU1868837136.USD","LU1868836757.USD","LU1814569148.SGD","LU2112291526.USD","SG9999017495.SGD","LU2491050154.USD","IE0009355771.USD","LU2552382215.SGD","LU2168563687.JPY","LU1989771016.USD","LU0316494557.USD","BK4581","IE00BK4W5L77.USD","LU0203202063.USD","LU1291159041.SGD","SGXZ31699556.SGD","LU0823416689.USD","LU0203201768.USD","LU1093756325.SGD","LU0097036916.USD","LU1623119135.USD","LU2361044865.SGD","SG9999018857.SGD","LU1551013425.SGD","LU2168564222.USD","IE00BJT1NW94.SGD","LU2361044949.HKD","SG9999014880.SGD","LU2552382132.HKD","LU1712237335.SGD","SGXZ57979304.SGD","LU0320765059.SGD","LU1232071149.USD","LU0106261372.USD","LU0823434583.USD","LU0471298777.SGD","BK4533","IE0002141913.USD","LU1988902786.USD","LU1023059063.AUD","LU2360106947.USD","LU2602419157.SGD","LU1868837300.USD","LU0096364046.USD","SG9999014898.SGD","SG9999015945.SGD","LU2361045086.USD","IE00BWXC8680.SGD","LU0689472784.USD","LU0823434740.USD","LU0820561909.HKD","IE00BJLML261.HKD","LU1974910355.USD","LU0061475181.USD","LU1093756168.USD","LU2168564495.EUR","IE00BKPKM429.USD","SG9999014906.USD","LU1551013342.USD","LU0323591593.USD","SG9999015986.USD","LU0708995401.HKD","LU0882574139.USD","LU2552382058.USD","LU0456855351.SGD","LU0094547139.USD","LU2417539215.USD","SG9999015952.SGD","LU0417517546.SGD","LU0114720955.EUR","LU1280957306.USD","LU1548497426.USD","LU2750360997.AUD","LLY","LU1057294990.SGD","LU2746668461.USD","LU2237443382.USD","LU2324357040.USD","LU0432979614.USD","LU2265009873.SGD","LU2491050071.SGD","LU2471134523.USD","LU1035775433.USD","LU0006306889.USD","LU2357305700.SGD","LU0882574055.USD","IE00B1XK9C88.USD","LU0354030511.USD","LU1366192091.USD","LU2236285917.USD","SG9999014914.USD","LU2237438978.USD","LU2237443978.SGD"],"gpt_icon":0},{"id":"1100423352","title":"FDA：正式批准Pirtobrutinib用于慢性淋巴细胞白血病和小淋巴细胞淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1100423352","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100423352?lang=zh_cn&edition=full","pubTime":"2025-12-04 01:37","pubTimestamp":1764783433,"startTime":"0","endTime":"0","summary":"FDA：正式批准Pirtobrutinib用于慢性淋巴细胞白血病和小淋巴细胞淋巴瘤","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491050071.SGD","IE00BJLML261.HKD","BK4599","IE00BKDWB100.SGD","LU2063271972.USD","LU2237438978.USD","IE00BK4W5L77.USD","LU0006306889.USD","LU1804176565.USD","LU2361044949.HKD","SG9999013999.USD","LU2746668974.SGD","LU0353189680.USD","LU1814569148.SGD","LU2471134523.USD","LU2237443465.HKD","LU0708995401.HKD","LU2361044865.SGD","LU0823416689.USD","LU0256863811.USD","LU1366192091.USD","LU1720051108.HKD","LU1548497426.USD","LU2106854487.HKD","SG9999001176.USD","LU1267930730.SGD","LU0820561909.HKD","SG9999014880.SGD","SG9999015952.SGD","LU2265009873.SGD","LU2264538146.SGD","LU1623119135.USD","LU0203202063.USD","LU0320765992.SGD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2461242641.AUD","LU0266013472.USD","IE00BWXC8680.SGD","LU0256863902.USD","LU0456855351.SGD","LU2237443895.HKD","LU2168564065.EUR","LU1093756168.USD","LU1064131342.USD","LU2456880835.USD","LU0096364046.USD","BK4516","LU0203201768.USD","SG9999018857.SGD","LU0417517546.SGD","LU0823434740.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU1291159041.SGD","LU2552382215.SGD","LU2462157665.USD","LU0106261372.USD","BK4007","LU1868836914.USD","SG9999014898.SGD","LU1551013342.USD","LU1551013425.SGD","LU2552382132.HKD","LU0354030511.USD","LU2168564149.EUR","IE00B1XK9C88.USD","LU2087625088.SGD","SGXZ57979304.SGD","LU2168564222.USD","LU2237443549.SGD","LU1232071149.USD","LU0198837287.USD","LU0471298777.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","LU0640476718.USD","LU2491050154.USD","LU0466842654.USD","LU2023250504.SGD","LU2112291526.USD","LU1720051017.SGD","LU2417539215.USD","GB00BDT5M118.USD","LU1974910355.USD","LU0289739699.SGD","IE0002141913.USD","LU0320765059.SGD","LU0471298694.HKD","LU2108987350.USD","LU2168563687.JPY","LU2552382058.USD","BK4533","IE00BJT1NW94.SGD","LU1280957306.USD","LU2468319806.SGD","BK4585","SGXZ51526630.SGD","SG9999018865.SGD","IE00B4R5TH58.HKD","SG9999014906.USD","LU1989771016.USD","IE0004445239.USD","LU1983299246.USD","LU1061106388.HKD","LU2236285917.USD","SG9999017495.SGD","LU2750360641.GBP","LU1988902786.USD","LU1868837136.USD","LU1868836757.USD","LU0109394709.USD","LU0114720955.EUR","LU0823434583.USD","SGXZ99366536.SGD","LU0882574139.USD","BK4588","LU2746668461.USD","LU0109391861.USD","LU2237443382.USD","BK4534","LLY","LU2237443978.SGD","LU2357305700.SGD","LU0820561818.USD","LU2602419157.SGD","LU0079474960.USD","LU0353189763.USD","LU2360106947.USD","LU2211815571.USD","LU0316494557.USD","IE00B2B36J28.USD","LU2237443622.USD","IE00BK4W5M84.HKD","LU1712237335.SGD","LU2324357040.USD","LU2168564495.EUR","LU0385154629.USD","SG9999014914.USD","LU1023059063.AUD","LU1057294990.SGD","SGXZ31699556.SGD","LU2471134952.CNY","LU0058720904.USD","LU0097036916.USD","LU0672654240.SGD","LU2089984988.USD","LU2471134796.USD","LU0354030438.USD","LU0432979614.USD","LU0234572021.USD","LU0943347566.SGD","LU1069344957.HKD","LU0889565916.HKD","LU0689472784.USD","LU1868837300.USD","IE00BKPKM429.USD","LU2361045086.USD","SG9999001176.SGD","LU2491049909.HKD","SG9999015986.USD","LU1868836591.USD","LU0122379950.USD","LU0882574055.USD","LU2750360997.AUD","LU1127390331.HKD","LU0094547139.USD","LU0786609619.USD","BK4581","LU2471134879.HKD","LU0238689110.USD","LU1035775433.USD","LU1917777945.USD","LU1323610961.USD","SG9999015978.USD","LU0323591593.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2588991019","title":"大行评级丨美银：大幅上调礼来目标价至1286美元 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2588991019","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588991019?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:37","pubTimestamp":1764751022,"startTime":"0","endTime":"0","summary":"美银将礼来的目标价从950美元大幅上调至1286美元，并重申“买入”评级。分析师看好礼来的核心理由在于其GLP-1药物Zepbound和Mounjaro在大型肥胖症和糖尿病市场中保持\"第一名\"地位。尽管该领域竞争复杂，但礼来仍稳居领先地位。此外，礼来的新药开发进度快于预期，分析师预计口服药物orforglipron将于2026年初，而非此前预期的2026年末推出，这推升了其对该公司未来一年的营收和盈利预测。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251203/31841473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LLY"],"gpt_icon":0},{"id":"2588563740","title":"看好药物研发管线前景，美银大幅上调礼来目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2588563740","media":"华尔街见闻","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588563740?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:22","pubTimestamp":1764685327,"startTime":"0","endTime":"0","summary":"美银看好礼来的核心理由包括：口服GLP-1药物orforglipron上市时间提前至2026年初，新药研发进度超预期；减肥和糖尿病药物Zepbound和Mounjaro保持市场领先地位。该行大幅上调礼来目标价至1,286美元，认为其还有22%上涨空间，重申买入评级。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3760548","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3760548","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"看好药物研发管线前景，美银大幅上调礼来目标价","news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY"],"gpt_icon":0},{"id":"2588033793","title":"凌科药业递交赴港IPO申请：核心在研产品面临同类竞品挤压，短期现金流恶化","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033793","media":"蓝鲸新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033793?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:37","pubTimestamp":1764661069,"startTime":"0","endTime":"0","summary":"《招股书》显示，凌科药业定位为自身免疫及炎症疾病领域创新药企，核心管线聚焦JAK-STAT信号通路，拥有三款临床阶段候选药物。若IPO募资不及预期，核心产品III期临床可能因资金不足被迫中断。总体而言，凌科药业在JAK抑制剂领域布局具有一定潜力，但其财务数据不容乐观，赴港IPO或许是此类公司生死时速中的必然选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120215441895263f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120215441895263f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU0359201612.USD","LU2543165471.USD","BK1191","LU1023057109.AUD","LLY","LU0359201885.HKD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2588160081","title":"贝伦贝格：将礼来目标价上调至950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588160081","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588160081?lang=zh_cn&edition=full","pubTime":"2025-12-02 13:42","pubTimestamp":1764654147,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2746668461.USD","LLY","LU2112291526.USD","LU1623119135.USD","LU0106261372.USD","LU2552382132.HKD","LU0097036916.USD","LU0109394709.USD","LU0471298777.SGD","SG9999001176.SGD","LU1064131342.USD","SG9999014914.USD","LU0006306889.USD","LU2168563687.JPY","LU0198837287.USD","LU2456880835.USD","LU0882574139.USD","LU1057294990.SGD","LU1868837136.USD","LU2361045086.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU0320765059.SGD","LU2552382058.USD","BK4516","SGXZ99366536.SGD","BK4007","LU2357305700.SGD","LU1804176565.USD","LU0094547139.USD","IE00B4R5TH58.HKD","LU2602419157.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","LU2236285917.USD","LU2168564222.USD","LU2237443382.USD","LU0203201768.USD","LU2324357040.USD","LU1974910355.USD","LU1267930730.SGD","LU2106854487.HKD","LU2168564065.EUR","LU2063271972.USD","LU2237443465.HKD","LU2237443895.HKD","LU0354030438.USD","LU0256863902.USD","LU0256863811.USD","LU1814569148.SGD"],"gpt_icon":0},{"id":"2588685700","title":"礼来旗下减肥药Zepbound降价至多14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588685700","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588685700?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:44","pubTimestamp":1764639894,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0058720904.USD","LU1974910355.USD","LLY","LU0114720955.EUR","LU1917777945.USD","LU2602419157.SGD","LU0203202063.USD","SGXZ57979304.SGD","LU0316494557.USD","LU2023250504.SGD","LU2750360997.AUD","IE00BKDWB100.SGD","LU0079474960.USD","LU0471298694.HKD","IE0009355771.USD","IE00B1XK9C88.USD","LU2456880835.USD","LU1061106388.HKD","LU0823434583.USD","LU0203201768.USD","LU0882574055.USD","LU0882574139.USD","BK4533","LU0466842654.USD","SGXZ81514606.USD","LU1127390331.HKD","LU2168564495.EUR","LU1064131342.USD","LU1989771016.USD","IE00BJLML261.HKD","LU1804176565.USD","LU0256863902.USD","LU0323591593.USD","LU0238689110.USD","BK4534","LU0096364046.USD","LU0889565916.HKD","LU1057294990.SGD","LU2237443382.USD","LU2462157665.USD","LU1868836757.USD","LU2491050154.USD","LU2461242641.AUD","LU2237443549.SGD","LU0353189763.USD","LU0823434740.USD","LU1868836591.USD","SG9999017495.SGD","LU2491050071.SGD","SG9999013999.USD"],"gpt_icon":0},{"id":"2588706541","title":"礼来下调Zepbound减肥药现金价格，最低至每月299美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706541","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588706541?lang=zh_cn&edition=full","pubTime":"2025-12-02 06:32","pubTimestamp":1764628333,"startTime":"0","endTime":"0","summary":"从12月1日起，持有效处方的自费患者可在LillyDirect平台上，以每月299至449美元的价格购买Zepbound瓶装产品，具体价格取决于剂量，而此前的价格范围为每月349美元至499美元。礼来股价周一下跌1.48%，但今年以来累计上涨超36%，上月成为首家市值破万亿美元的医疗保健企业。","market":"other","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3760483","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3760483","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","BK4533","LLY"],"gpt_icon":1},{"id":"2588470864","title":"礼来下调Zepbound瓶装药品的现金售价","url":"https://stock-news.laohu8.com/highlight/detail?id=2588470864","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588470864?lang=zh_cn&edition=full","pubTime":"2025-12-02 04:47","pubTimestamp":1764622020,"startTime":"0","endTime":"0","summary":"美股周一尾盘，礼来股价下跌1.65%。据报道，礼来公司在LillyDirect平台下调Zepbound瓶装药品的现金售价。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-02/doc-infzivcx0828722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1814569148.SGD","BK4581","LU1983299246.USD","BK4599","LLY","LU1917777945.USD","LU1623119135.USD","LU2471134523.USD","LU0456855351.SGD","SGXZ31699556.SGD","LU1267930730.SGD","LU1023059063.AUD","LU2063271972.USD","IE00BJJMRZ35.SGD","LU2471134796.USD","LU0471298777.SGD","LU0471298694.HKD","LU1035775433.USD","LU2361045086.USD","LU1868837300.USD","SG9999015952.SGD","LU0320765059.SGD","LU1868837136.USD","LU0823434583.USD","LU0882574055.USD","LU0882574139.USD","BK4585","IE0002141913.USD","LU1280957306.USD","SGXZ81514606.USD","LU0353189680.USD","LU1064131342.USD","LU1804176565.USD","LU2087625088.SGD","LU0256863902.USD","LU0323591593.USD","BK4534","LU0889565916.HKD","LU2462157665.USD","LU0094547139.USD","LU1868836757.USD","LU1232071149.USD","LU2491050154.USD","LU2461242641.AUD","LU2089984988.USD","LU0820561909.HKD","IE00BFTCPJ56.SGD","LU2491050071.SGD","LU1720051017.SGD","SG9999013999.USD"],"gpt_icon":0},{"id":"2588780207","title":"礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2588780207","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588780207?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:01","pubTimestamp":1764597669,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，随着与竞争对手$诺和诺德$的竞争日趋激烈，$礼来$再次下调其减肥药Zepbound入门剂量的价格。礼来在一份声明中表示，自周一起，现金自费购药者购买最低剂量的Zepbound每月费用为299美元，较之前价格优惠约50美元。礼来未调整更高剂量的价格，该系列仍维持每月499美元的售价。这是该公司今年第二次通过LillyDirect平台下调Zepbound的价格。根据协议，礼来将下调Zepbound多剂量笔的价格。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376226.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"礼来下调Zepbound入门剂量价格，减肥药竞争加剧推高行业压力","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY"],"gpt_icon":1},{"id":"1170015358","title":"礼来：Zepbound自费项目患者所有其他批准剂量每月449美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170015358","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170015358?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:00","pubTimestamp":1764594014,"startTime":"0","endTime":"0","summary":"礼来：Zepbound自费项目患者所有其他批准剂量每月449美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","SG9999014880.SGD","LU0234572021.USD","LU1023059063.AUD","LU1868837136.USD","LU1057294990.SGD","SG9999015952.SGD","LU2087625088.SGD","LU0203202063.USD","LU2552382132.HKD","LU1720051017.SGD","LU1868836591.USD","LU2168563687.JPY","LU0640476718.USD","LU1814569148.SGD","LU2089984988.USD","LU2361044949.HKD","LU0320765059.SGD","LU2237443549.SGD","LU0353189680.USD","IE00BKPKM429.USD","IE00BK4W5L77.USD","LU0316494557.USD","LU0256863811.USD","LU1232071149.USD","LU1061106388.HKD","LU2211815571.USD","SG9999014914.USD","LU0354030438.USD","LU0456855351.SGD","LU1069344957.HKD","LU1093756168.USD","LU2324357040.USD","LU0466842654.USD","LU0289739699.SGD","LU2491050071.SGD","SGXZ81514606.USD","LU1983299246.USD","LU0708995401.HKD","LU1366192091.USD","LU2112291526.USD","IE00BJLML261.HKD","IE00BKDWB100.SGD","LU2461242641.AUD","LU0385154629.USD","LU2552382215.SGD","LU2746668461.USD","LU0471298694.HKD","LU0786609619.USD","IE00B2B36J28.USD","LU1064131342.USD","LU2471134523.USD","LU2491050154.USD","LU2361044865.SGD","LU2108987350.USD","LU0097036916.USD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU1720051108.HKD","LU1551013342.USD","SG9999018857.SGD","IE00BFTCPJ56.SGD","LU0109391861.USD","LU1868836757.USD","IE0004445239.USD","LU0882574139.USD","LU0266013472.USD","IE00BWXC8680.SGD","LU0096364046.USD","LU2357305700.SGD","LU0882574055.USD","SGXZ57979304.SGD","LU0823434740.USD","LU2360106947.USD","LU0432979614.USD","IE00BK4W5M84.HKD","LU0320765992.SGD","LU2168564149.EUR","LU0006306889.USD","LU0094547139.USD","IE00B4R5TH58.HKD","LU1623119135.USD","LU0471298777.SGD","LU2237438978.USD","LU2106854487.HKD","LU1917777945.USD","LU1280957306.USD","LU1093756325.SGD","LU2552382058.USD","LU0820561818.USD","LU2746668974.SGD","LU0122379950.USD","LU0079474960.USD","LU2750360997.AUD","LU1267930730.SGD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU0889565916.HKD","LU1804176565.USD","LU2237443622.USD","SG9999001176.USD","LU1989771016.USD","LU2361045086.USD","LU2468319806.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU2417539215.USD","LU0943347566.SGD","LU0672654240.SGD","LU1035775433.USD","BK4533","LU2168564495.EUR","LU2462157665.USD","LU1127390331.HKD","LU0198837287.USD","LU2265009873.SGD","BK4516","SG9999013999.USD","LU0203201768.USD","LU0823434583.USD","BK4581","IE00BJJMRZ35.SGD","LU0238689110.USD","LU2236285917.USD","LU1323610961.USD","SG9999015945.SGD","SG9999015986.USD","SG9999017495.SGD","LU1291159041.SGD","LU2237443382.USD","LU2168564222.USD","BK4588","IE00BJT1NW94.SGD","LU2602419157.SGD","SG9999001176.SGD","LU1551013425.SGD","SG9999014898.SGD","LU2168564065.EUR","LU1548497426.USD","LU0323591593.USD","LU0114720955.EUR","BK4585","LU0820561909.HKD","BK4007","SGXZ99366536.SGD","LU0689472784.USD","LU2237443895.HKD","IE0002141913.USD","BK4599","LU1868837300.USD","LU2750360641.GBP","LU0823416689.USD","LU2456880835.USD","LU0354030511.USD","LU2491049909.HKD","LU0058720904.USD","SG9999015978.USD","LU2237443978.SGD","BK4534","IE00B1XK9C88.USD","LLY","LU0109394709.USD","LU2063271972.USD","LU2471134796.USD","SG9999018865.SGD","LU2237443465.HKD","LU0106261372.USD","LU0353189763.USD","LU1974910355.USD","LU2471134879.HKD","LU1988902786.USD","LU2264538146.SGD","IE0009355771.USD","LU1712237335.SGD","LU2471134952.CNY","SG9999014906.USD","LU0256863902.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"1109822769","title":"Adverum Biotechnologies Inc：收购要约计划于2025年12月8日东部时间晚上11:59过后一分钟到期","url":"https://stock-news.laohu8.com/highlight/detail?id=1109822769","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109822769?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:02","pubTimestamp":1764590529,"startTime":"0","endTime":"0","summary":"Adverum Biotechnologies Inc：收购要约计划于2025年12月8日东部时间晚上11:59过后一分钟到期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU0471298694.HKD","LU0354030511.USD","LU2471134523.USD","LU2491050154.USD","LU2417539215.USD","LU2236285917.USD","LU0289739699.SGD","LU2552382132.HKD","LU0238689110.USD","LU0820561818.USD","LU0323591593.USD","LU1868837300.USD","LU1868837136.USD","LU1093756325.SGD","BK4599","LU0058720904.USD","LU0266013472.USD","LU2750360997.AUD","LU1983299246.USD","LU0320765992.SGD","SGXZ31699556.SGD","LU1232071149.USD","LU1551013342.USD","LU0882574055.USD","LU1366192091.USD","LU2602419157.SGD","BK4516","LU0385154629.USD","SG9999015986.USD","LU0786609619.USD","LU1712237335.SGD","LU0672654240.SGD","LU0198837287.USD","LU2491050071.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2471134952.CNY","BK4581","LU2023250504.SGD","IE00BJT1NW94.SGD","LU0203202063.USD","LU2456880835.USD","IE00BKPKM429.USD","BK4533","LU1814569148.SGD","LU0256863811.USD","LU2750360641.GBP","BK4139","LU1093756168.USD","SG9999018865.SGD","LU0109394709.USD","LU0689472784.USD","LU1291159041.SGD","LU1280957306.USD","LU0234572021.USD","LU0114720955.EUR","LU2237443382.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU2237443465.HKD","LU2237443549.SGD","LU1064131342.USD","IE0004445239.USD","LU1720051108.HKD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","SG9999014880.SGD","LU1267930730.SGD","LU1057294990.SGD","LU0079474960.USD","IE00BKDWB100.SGD","LLY","LU1127390331.HKD","LU1868836914.USD","LU0823416689.USD","LU0823434740.USD","LU0471298777.SGD","SG9999018857.SGD","LU0094547139.USD","LU1868836757.USD","LU0320765059.SGD","LU2265009873.SGD","LU1974910355.USD","BK4588","LU2360106947.USD","LU0061475181.USD","LU2168564065.EUR","IE00BJLML261.HKD","LU0820561909.HKD","SGXZ57979304.SGD","LU2168564149.EUR","LU0889565916.HKD","LU2462157665.USD","SG9999015978.USD","SGXZ81514606.USD","LU2461242641.AUD","LU0823434583.USD","LU0432979614.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU2237443895.HKD","LU2552382215.SGD","LU0203201768.USD","SG9999001176.USD","LU2168563687.JPY","LU0456855351.SGD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU2468319806.SGD","IE00BWXC8680.SGD","BK4007","LU1035775433.USD","LU0417517546.SGD","LU1720051017.SGD","SG9999015945.SGD","LU2106854487.HKD","LU2361044949.HKD","LU1988902786.USD","IE00B2B36J28.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","GB00BDT5M118.USD","LU1917777945.USD","LU1623119135.USD","LU0316494557.USD","LU1804176565.USD","LU0353189763.USD","LU2357305700.SGD","LU2112291526.USD","SGXZ51526630.SGD","LU1023059063.AUD","BK4585","LU1551013425.SGD","LU1061106388.HKD","LU1989771016.USD","BK4534","SG9999001176.SGD","LU2491049909.HKD","LU2746668461.USD","SG9999013999.USD","LU2168564495.EUR","SGXZ99366536.SGD","LU2324357040.USD","ADVM","LU0256863902.USD","LU0122379950.USD","LU2089984988.USD","LU0943347566.SGD","LU1548497426.USD","SG9999014914.USD","LU2264538146.SGD","LU0109391861.USD","LU2361045086.USD","LU2168564222.USD","LU0354030438.USD","LU2211815571.USD","LU2063271972.USD","LU2237438978.USD","LU2087625088.SGD","LU0353189680.USD","LU0882574139.USD","LU2237443622.USD","LU2746668974.SGD","IE00B1XK9C88.USD","LU1323610961.USD","LU0097036916.USD","LU0640476718.USD","LU1069344957.HKD","SG9999014906.USD","SG9999017495.SGD","IE0009355771.USD","LU0106261372.USD","LU2361044865.SGD","SG9999014898.SGD","IE0002141913.USD","LU1868836591.USD","SG9999015952.SGD","LU0466842654.USD","LU2471134796.USD"],"gpt_icon":0},{"id":"2588090743","title":"诺和诺德年内股价下跌43.10%！礼来替尔泊肽证明自己是真正的“减肥药之王”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588090743","media":"GLP1减重宝典","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588090743?lang=zh_cn&edition=full","pubTime":"2025-12-01 12:19","pubTimestamp":1764562796,"startTime":"0","endTime":"0","summary":"在此背景下，诺和诺德股价近期出现明显回落，而礼来则迎来新一轮估值上升。截至2025年9月，礼来在美国GLP-1药物处方份额达到58%，诺和诺德为42%。替尔泊肽因显著优于司美格鲁肽的减重幅度与代谢改善效果，被视为“下一代减肥药”的代表。在替尔泊肽的带动下，礼来股价一路上涨，市值突破1万亿美元，成为全球首批迈入该规模的医疗公司。资本市场普遍认为，礼来已成为GLP-1与肥胖代谢药物领域的新霸主。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201125219a4c4e522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201125219a4c4e522&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","LU0061475181.USD","LU1868837300.USD","SGXZ57979304.SGD","LU0708995401.HKD","LU2471134952.CNY","LU2456880835.USD","LU2552382215.SGD","SG9999001176.USD","LU0823434740.USD","LU2471134523.USD","LU0889565916.HKD","LU2112291526.USD","LU0823434583.USD","LU1057294990.SGD","LU1232071149.USD","LU0432979614.USD","LU0094547139.USD","LU0820561818.USD","SGXZ81514606.USD","LU0096364046.USD","LLY","BK4599","IE00BFTCPJ56.SGD","LU0353189763.USD","IE00BWXC8680.SGD","LU0354030438.USD","LU1814569148.SGD","LU1551013342.USD","LU2750360997.AUD","SG9999015945.SGD","LU0943347566.SGD","LU0154236417.USD","LU2471134796.USD","IE00BJLML261.HKD","LU0109394709.USD","LU0882574055.USD","NVO","LU0320765059.SGD","LU0234572021.USD","LU2236285917.USD","LU2237443465.HKD","LU0354030511.USD","LU0316494557.USD","LU1069344957.HKD","LU2471134879.HKD","LU0006306889.USD","LU2552382058.USD","LU2552382132.HKD","LU2750360641.GBP"],"gpt_icon":1},{"id":"2588719603","title":"礼来之后，谁是下一个万亿药企？","url":"https://stock-news.laohu8.com/highlight/detail?id=2588719603","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588719603?lang=zh_cn&edition=full","pubTime":"2025-12-01 07:31","pubTimestamp":1764545500,"startTime":"0","endTime":"0","summary":"而领跑者礼来就是以1万亿美元市值开创行业先河。领跑者礼来以1万亿美元市值开创行业先河，其54.41倍的市盈率充分反映了市场对公司在代谢疾病领域，特别是GLP-1受体激动剂赛道的高度认可。细分领域的差异化表现在代谢疾病领域，诺和诺德与礼来共同引领GLP-1浪潮，然而前者年内股价下跌43.10%的表现，揭示了市场竞争的激烈程度和定价压力对企业的影响。随着礼来叩开\"万亿市值时代\"的大门，全球医药行业正进入一个创新加速、价值重估的新阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201075228a71b799c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201075228a71b799c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4516","LU1280957306.USD","LU2468319806.SGD","LU2361045086.USD","LU2211815571.USD","LU1093756325.SGD","LU0234572021.USD","LU2237443895.HKD","LU0079474960.USD","LU1093756168.USD","LU1551013342.USD","LU1974910355.USD","LU0689472784.USD","LU0097036916.USD","LU1064131342.USD","LLY","IE0002141913.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU0672654240.SGD","SG9999017495.SGD","LU1988902786.USD","SGXZ51526630.SGD","LU0256863902.USD","LU1720051108.HKD","SG9999014898.SGD","SG9999015978.USD","NVO","LU2168564222.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU2417539215.USD","LU0006306889.USD","IE00B4R5TH58.HKD","LU1323610961.USD","LU2746668461.USD","LU1366192091.USD","LU2112291526.USD","LU2491050154.USD","IE00BJJMRZ35.SGD","LU0094547139.USD","BK4581","BK4533","IE00BK4W5L77.USD","LU1868837136.USD","LU1551013425.SGD","IE00BJLML261.HKD","LU2461242641.AUD","LU2491049909.HKD","LU2168563687.JPY"],"gpt_icon":1},{"id":"2586473564","title":"美股异动 | 医药板块集体走低 礼来(LLY.US)跌2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473564","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586473564?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:00","pubTimestamp":1764342000,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，医药板块集体走低。截至发稿，礼来(LLY.US)跌2.4%，该股周三触及历史新高且市值突破1万亿美元。诺和诺德(NVO.US)、联合医疗(UTHR.US)、联合健康(UNH.US)微跌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1804176565.USD","BK4007","LU0320765992.SGD","LU2236285917.USD","LU2462157665.USD","LU1989771016.USD","LU0353189763.USD","159938","LU2237443978.SGD","LU2265009873.SGD","LLY","LU0823434583.USD","BK4588","LU0203202063.USD","LU2237443895.HKD","LU2361044949.HKD","LU2471134879.HKD","LU2361045086.USD","LU1093756168.USD","LU0354030511.USD","09939","LU0289739699.SGD","LU0385154629.USD","SG9999001176.USD","IE0004445239.USD","LU0823416689.USD","LU0006306889.USD","SGXZ51526630.SGD","LU0198837287.USD","LU1868836591.USD","LU2106854487.HKD","LU1280957306.USD","LU2237443465.HKD","LU1814569148.SGD","LU1232071149.USD","LU1127390331.HKD","SG9999001176.SGD","SG9999015986.USD","LU1974910355.USD","LU2417539215.USD","LU1868836757.USD","LU1035775433.USD","LU1064131342.USD","LU2750360641.GBP","LU0882574139.USD","LU2552382215.SGD","LU1551013425.SGD","SG9999013999.USD","LU1057294990.SGD","LU2552382132.HKD"],"gpt_icon":0},{"id":"2586281572","title":"头家万亿美元市值药企诞生！制药行业估值天花板重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2586281572","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586281572?lang=zh_cn&edition=full","pubTime":"2025-11-27 14:29","pubTimestamp":1764224943,"startTime":"0","endTime":"0","summary":"截至11月26日，礼来总市值为1.04万亿美元。业内表示，礼来成功闯入万亿美元“俱乐部”，重塑了全球制药行业的估值天花板。在替尔泊肽和阿贝西利的助力下，礼来2025Q3业绩亮眼，第三季度公司营收176.01亿美元，同比增长54%。如礼来以 2.617亿美元收购Adverum，获得其视网膜疾病基因疗法管线。根据数据统计，2025年内，礼来密集完成31笔交易，总金额超206亿美元，覆盖核药、基因疗法、AI制药等前沿领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127143150951d23aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127143150951d23aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999018857.SGD","LU0823434740.USD","LU1280957306.USD","LU2237443622.USD","IE00BK4W5L77.USD","LU1291159041.SGD","LU1712237335.SGD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2746668974.SGD","LU1814569148.SGD","LU2237443465.HKD","SG9999014898.SGD","LU0708995401.HKD","LU2361044865.SGD","LU0672654240.SGD","LU2236285917.USD","LU2471134796.USD","LU0354030511.USD","LU0432979614.USD","IE00B1XK9C88.USD","SG9999017495.SGD","LU1069344957.HKD","BK4516","LU1232071149.USD","LU2237443549.SGD","IE00BJJMRZ35.SGD","SG9999001176.SGD","LU2265009873.SGD","SG9999015945.SGD","LU2264538146.SGD","LU0640476718.USD","LU1868836591.USD","LU0882574055.USD","LU2112291526.USD","LU2237443382.USD","LLY","BK4534","IE0002141913.USD","LU0266013472.USD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1917777945.USD","LU0256863902.USD","LU0353189763.USD","LU2108987350.USD","LU0323591593.USD","LU0096364046.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"1124588657","title":"Form 4 | ELI LILLY高管 LILLY ENDOWMENT INC 减持84533股","url":"https://stock-news.laohu8.com/highlight/detail?id=1124588657","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124588657?lang=zh_cn&edition=full","pubTime":"2025-11-27 13:51","pubTimestamp":1764222674,"startTime":"0","endTime":"0","summary":"ELI LILLY & Co的10%持有者LILLY ENDOWMENT INC于2025年11月25日通过多笔交易累计减持84533股普通股，价格区间为1073.735至1107.48美元每股。高管的大规模减持通常表示对公司未来股价预期较为悲观，可能是一种利空信号，投资者需要给予密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Form 4 | ELI LILLY高管 LILLY ENDOWMENT INC 减持84533股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY"],"gpt_icon":0},{"id":"2586228137","title":"礼来何以称王？","url":"https://stock-news.laohu8.com/highlight/detail?id=2586228137","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586228137?lang=zh_cn&edition=full","pubTime":"2025-11-27 10:08","pubTimestamp":1764209328,"startTime":"0","endTime":"0","summary":"近日，礼来成为全球首家市值突破万亿美元的制药企业，这一里程碑不仅标志着资本市场的认可，更象征着医药行业进入一个全新的价值纪元。礼来通过一系列前瞻性的战略布局，将GLP-1推向了“全能型药物”的新高度。在靶点布局上，礼来不走寻常路，积极探索多靶点协同作用的奥秘。为了提高患者的用药便利性和依从性，礼来在长效化技术方面投入了大量研发精力。礼来还积极拓展GLP-1的适应症范围，将其应用拓展到更多疾病领域。02礼来何以称王？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127101122a7141b07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127101122a7141b07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2106854487.HKD","LU0316494557.USD","BK4585","LU2462157665.USD","LU0198837287.USD","LU1023059063.AUD","LU2237438978.USD","LU2471134879.HKD","SG9999015952.SGD","LU0238689110.USD","SGXZ99366536.SGD","LU0640476718.USD","LU0122379950.USD","LLY","LU0417517546.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1127390331.HKD","LU2112291526.USD","LU2168564495.EUR","SG9999014906.USD","SG9999017495.SGD","LU0689472784.USD","SG9999001176.USD","LU0114720955.EUR","SG9999018857.SGD","IE00BWXC8680.SGD","LU1093756168.USD","LU1093756325.SGD","LU0256863902.USD","LU2237443549.SGD","LU0323591593.USD","LU2361044865.SGD","LU2491049909.HKD","LU0353189763.USD","LU1280957306.USD","LU0289739699.SGD","LU0234572021.USD","LU0786609619.USD","LU1868836757.USD","LU0882574139.USD","LU0823434740.USD","LU2491050071.SGD","LU2750360641.GBP","BK4533","LU0256863811.USD","LU0456855351.SGD","LU2461242641.AUD","LU1712237335.SGD","IE0009355771.USD"],"gpt_icon":1},{"id":"2586122815","title":"礼来跌0.90% 股价跌破1100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2586122815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586122815?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:35","pubTimestamp":1764171324,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时35分，礼来股票出现波动，股价急速跳水0.90%。截至发稿，该股报1100.00美元/股，成交量80.8322万股，换手率0.09%，振幅1.08%。礼来股票所在的制药行业中，整体跌幅为0.97%。年初至今，诺和诺德股价已下跌近5成，市值缩水约1900亿美元。今年4月，礼来公布了其口服小分子GLP-1药物orforglipron的研究结果，并表示预计将在今年年底前提交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126233525a7134a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126233525a7134a32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2750360997.AUD","SG9999014880.SGD","LU2357305700.SGD","LU0882574055.USD","LU0823416689.USD","LU2089984988.USD","SGXZ99366536.SGD","LU0234572021.USD","LU0203201768.USD","LU2461242641.AUD","IE00BK4W5M84.HKD","IE0002141913.USD","IE00BK4W5L77.USD","LU2264538146.SGD","LU0058720904.USD","LU0316494557.USD","LU2063271972.USD","LU2552382215.SGD","LU0094547139.USD","LU1267930730.SGD","LLY","LU2491050071.SGD","LU2468319806.SGD","LU2471134523.USD","LU0689472784.USD","LU1093756325.SGD","SGXZ51526630.SGD","LU1366192091.USD","LU2237443465.HKD","LU0097036916.USD","BK4588","LU0109394709.USD","LU2471134952.CNY","SG9999018857.SGD","LU1323610961.USD","LU1127390331.HKD","LU0786609619.USD","LU2106854487.HKD","LU0289739699.SGD","LU2211815571.USD","LU2746668974.SGD","LU0889565916.HKD","LU2456880835.USD","LU0061475181.USD","LU1868836914.USD","LU1291159041.SGD","LU1232071149.USD","LU2168564495.EUR","LU2360106947.USD","SGXZ57979304.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":-0.0606},{"period":"1month","weight":0.0913},{"period":"3month","weight":0.3893},{"period":"6month","weight":0.3123},{"period":"1year","weight":0.2237},{"period":"ytd","weight":0.3087}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立，其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司开发，制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来，为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.511111,"avgChangeRate":0.012368},{"month":2,"riseRate":0.511111,"avgChangeRate":0.000157},{"month":3,"riseRate":0.6,"avgChangeRate":0.012761},{"month":4,"riseRate":0.565217,"avgChangeRate":0.020234},{"month":5,"riseRate":0.413043,"avgChangeRate":0.010692},{"month":6,"riseRate":0.608696,"avgChangeRate":0.023694},{"month":7,"riseRate":0.543478,"avgChangeRate":-0.001439},{"month":8,"riseRate":0.413043,"avgChangeRate":0.003999},{"month":9,"riseRate":0.456522,"avgChangeRate":0.00229},{"month":10,"riseRate":0.586957,"avgChangeRate":0.015277},{"month":11,"riseRate":0.73913,"avgChangeRate":0.03111},{"month":12,"riseRate":0.565217,"avgChangeRate":0.028494}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}